NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
0.9211
Dollar change
-0.0249
Percentage change
-2.63
%
Index- P/E- EPS (ttm)-1.64 Insider Own8.46% Shs Outstand40.34M Perf Week-0.15%
Market Cap37.16M Forward P/E- EPS next Y-1.44 Insider Trans0.00% Shs Float36.92M Perf Month-14.71%
Enterprise Value-51.40M PEG- EPS next Q-0.33 Inst Own15.32% Short Float0.09% Perf Quarter21.20%
Income-65.22M P/S2.46 EPS this Y3.87% Inst Trans0.19% Short Ratio0.98 Perf Half Y-16.26%
Sales15.12M P/B0.32 EPS next Y3.36% ROA-38.20% Short Interest0.03M Perf YTD-23.75%
Book/sh2.86 P/C0.37 EPS next 5Y-8.69% ROE-45.40% 52W High1.58 -41.70% Perf Year-35.59%
Cash/sh2.49 P/FCF- EPS past 3/5Y-4.32% - ROIC-51.99% 52W Low0.64 43.92% Perf 3Y-82.94%
Dividend Est.- EV/EBITDA- Sales past 3/5Y282.32% 16.85% Gross Margin57.58% Volatility5.79% 6.05% Perf 5Y-
Dividend TTM- EV/Sales-3.40 EPS Y/Y TTM10.56% Oper. Margin-348.53% ATR (14)0.07 Perf 10Y-
Dividend Ex-Date- Quick Ratio9.18 Sales Y/Y TTM4413.19% Profit Margin-431.28% RSI (14)50.33 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio9.18 EPS Q/Q-22.70% SMA20-0.17% Beta-0.80 Target Price3.00
Payout- Debt/Eq0.10 Sales Q/Q- SMA50-0.30% Rel Volume0.48 Prev Close0.95
Employees105 LT Debt/Eq0.09 EarningsMay 07 BMO SMA200-10.75% Avg Volume33.76K Price0.92
IPOApr 30, 2021 Option/ShortNo / Yes EPS/Sales Surpr.-36.11% - Trades Volume16,172 Change-2.63%
Date Action Analyst Rating Change Price Target Change
May-25-21Initiated William Blair Outperform
May-25-21Initiated Morgan Stanley Overweight $22
May-25-21Initiated Jefferies Buy $28
May-24-21Initiated H.C. Wainwright Buy $25
Jun-09-25 09:00AM
May-07-25 08:00AM
Mar-20-25 07:22AM
Mar-18-25 03:30PM
Mar-06-25 08:30AM
08:00AM Loading…
Jan-10-25 08:00AM
Nov-25-24 04:01PM
Nov-15-24 11:02AM
11:01AM
Nov-06-24 08:00AM
Oct-31-24 08:00AM
Oct-01-24 08:00AM
Sep-24-24 08:00AM
Aug-08-24 08:00AM
Aug-01-24 08:00AM
04:01PM Loading…
Jun-12-24 04:01PM
Jun-06-24 11:15AM
May-22-24 08:00AM
May-13-24 01:53PM
08:00AM
May-01-24 07:00AM
Apr-18-24 04:10PM
Mar-20-24 01:52PM
08:15AM
Jan-05-24 04:01PM
Dec-21-23 07:31AM
Nov-09-23 04:24PM
04:01PM
04:01PM
Nov-06-23 09:05AM
06:23AM Loading…
Oct-04-23 06:23AM
Sep-13-23 08:00AM
Aug-10-23 08:00AM
Aug-09-23 07:37AM
Jul-19-23 08:34PM
Jun-29-23 07:11AM
06:49AM
Jun-21-23 09:03AM
07:30AM
Jun-12-23 07:30AM
May-19-23 06:04AM
May-12-23 08:00AM
May-05-23 07:33AM
Apr-17-23 09:00AM
Apr-05-23 01:40PM
Mar-28-23 08:00AM
Mar-24-23 08:06AM
Mar-20-23 12:44PM
08:00AM
Mar-16-23 06:47AM
Mar-01-23 06:01AM
Jan-30-23 08:00AM
Jan-13-23 05:24AM
Nov-21-22 10:31AM
Nov-13-22 07:29AM
Nov-10-22 04:30PM
Nov-09-22 08:00AM
Nov-07-22 08:00AM
Nov-02-22 08:00AM
Oct-31-22 08:00AM
Oct-27-22 07:00AM
Oct-06-22 11:45AM
Oct-03-22 04:30PM
Sep-20-22 04:30PM
Sep-07-22 04:01PM
12:00PM
Aug-15-22 06:14AM
Aug-11-22 09:14AM
Aug-09-22 04:15PM
Jul-07-22 04:15PM
Jul-03-22 10:08AM
Jun-22-22 01:34PM
06:00AM
Jun-06-22 04:15PM
07:32AM
May-20-22 11:30AM
May-19-22 06:32AM
May-11-22 04:15PM
Apr-29-22 10:30AM
Apr-06-22 04:15PM
Mar-25-22 07:15AM
Mar-07-22 08:00AM
Jan-21-22 03:41AM
Jan-18-22 03:00AM
Jan-13-22 04:34PM
Jan-10-22 10:00AM
Dec-13-21 04:05PM
Dec-07-21 08:00AM
Nov-24-21 09:20AM
Nov-12-21 08:00AM
07:00AM
Nov-10-21 08:00AM
Nov-04-21 04:00AM
Oct-28-21 01:23PM
Oct-18-21 08:00AM
Oct-13-21 08:00AM
Sep-13-21 12:38PM
Sep-09-21 08:00AM
Aug-12-21 08:00AM
Jul-30-21 10:00AM
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.